Concepedia

Maureen E. Keegan

ME

Statistics

Publications

8

Citations

301

H-Index

8

Active since

1982

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Maureen E. Keegan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacodynamics.

Publications per year

1982–1993

8

Publications

8

Long-term safety and efficacy profile of simvastatin

Stephen J. Boccuzzi, Tomás S. Bocanegra, J. Findlay Walker et al. · The American Journal of Cardiology · 1991 · 116 citations

, , +13

Inactivation of angiotensin ii receptors in bovine adrenal cortex by dithiothreitol further evidence for the essential nature of disulfide bonds

Raymond S.L. Chang, Victor J. Lotti, Maureen E. Keegan · Biochemical Pharmacology · 1982 · 38 citations

, , +17

Cholecystokinin antagonists. Synthesis of asperlicin analogs with improved potency and water solubility

Mark G. Bock, Robert M. DiPardo, Kenneth E. Rittle et al. · Journal of Medicinal Chemistry · 1986 · 34 citations · Full text

, , +8

Tifluadom, a κ-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist

Raymond S.L. Chang, Victor J. Lotti, Tsing B. Chen et al. · Neuroscience Letters · 1986 · 27 citations

, , +9

Characterization of [3H]pentagastrin binding in guinea pig gastric glands — An alternative convenient ligand for receptor binding assay

Raymond S.L. Chang, Victor J. Lotti, Maureen E. Keegan et al. · Biochemical and Biophysical Research Communications · 1986 · 27 citations

, , +9

1–5 of 8